FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy or in combination with other commonly prescribed medications for type 2 ...

FDA Warns About Counterfeit ExtenZe Dietary Supplements
The U.S. Food and Drug Administration is warning consumers about a potentially harmful product represented as "ExtenZe," a dietary supplement for male sexual enhancement. The counterfeit product looks similar to the actual product, but contains hidden ingredients that can cause serious harm to consumers...